

![]() |
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma |
|
Authors | ![]() | |
Published in | Cancer Cell. 2017, vol. 32, no. 6, p. 856-868.e5 | |
Abstract | While molecular subtypes of glioblastoma (GBM) are defined using gene expression and mutation profiles, we identify a unique subpopulation based on addiction to the high-affinity glucose transporter, Glut3. Although Glut3 is a known driver of a cancer stem cell phenotype, direct targeting is complicated by its expression in neurons. Using established GBM lines and patient-derived stem cells, we identify a subset of tumors within the "proneural" and "classical" subtypes that are addicted to aberrant signaling from integrin αvβ3, which activates a PAK4-YAP/TAZ signaling axis to enhance Glut3 expression. This defined subpopulation of GBM is highly sensitive to agents that disrupt this pathway, including the integrin antagonist cilengitide, providing a targeted therapeutic strategy for this unique subset of GBM tumors. | |
Keywords | Animals — Antineoplastic Agents/pharmacology — Brain Neoplasms/metabolism/mortality — Cell Line, Tumor — Gene Expression Profiling — Glioblastoma/metabolism/mortality — Glucose Transporter Type 3/metabolism — Humans — Integrin alphaVbeta3/metabolism — Kaplan-Meier Estimate — Mice — Mice, Nude — Signal Transduction — Snake Venoms/pharmacology — Transcriptome — Xenograft Model Antitumor Assays | |
Identifiers | PMID: 29198914 | |
Full text | ||
Structures | ||
Research groups | Génomique et métagénomique des produits sanguins labiles (956) Immunothérapie des cancers (42) Radicaux libres et cellules souches embryonnaires (60) | |
Citation (ISO format) | COSSET, Erika et al. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. In: Cancer Cell, 2017, vol. 32, n° 6, p. 856-868.e5. doi: 10.1016/j.ccell.2017.10.016 https://archive-ouverte.unige.ch/unige:111356 |